Related news from
Sat, 31 Jan 2026 07:30:00 +0000	The Exit Rush Is Over for Nontraded BDCs. Cash Keeps Coming Into Private Credit. The once-hot business of private credit got ice buckets of bad news in recent months, with the publicized failures of some borrowers. Just last week, BlackRock disclosed a 19% write-down in the net asset value of the loans owned at BlackRock TCP Capital one of the business-development companies that private-credit firms market to individual investors. Most of the good-size BDCs have diverse portfolios and credit loss histories that are as good or better than other debt categories.
Thu, 29 Jan 2026 20:18:26 +0000	This Florida Financial Consultant Bought 211,000 New Shares of Blackstone's BDC. Should You Follow? Blackstone Secured Lending Fund focuses on senior secured loans for private U.S. small and middle market companies.
Thu, 29 Jan 2026 11:00:00 +0000	Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2025 Financial Results and Conference Call SAN MATEO, Calif., January 29, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and full-year 2025 financial results conference call for Thursday, February 12, 2026, at 2:00 p.m. PT (5:00 p.m
Thu, 29 Jan 2026 07:26:00 +0000	Tenpoint wins FDA nod for combination presbyopia eye drop The biotech also raised $235 million in debt and equity funding to support marketing of the drop, which it claims to be an advance over existing treatments from AbbVie and others.
Thu, 29 Jan 2026 04:35:25 +0000	3 Low-Volatility Stocks We Find Risky Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.
Thu, 29 Jan 2026 03:15:00 +0000	Tenpoint Therapeutics Secures $235 Million through Series B Stock Financing and Credit Facility to Accelerate Commercialization of YUVEZZI™ LONDON & SEATTLE, January 29, 2026--Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced it has secured $235 million through the successful close of its Series B preferred stock financing and a credit facility.
Wed, 28 Jan 2026 17:18:00 +0000	Will Growth in Total Investment Income Continue for ARCC in 2026? Ares Capital's total investment income shows a 14.4% five-year (2019-2024) CAGR, with upward momentum into 2025.
Wed, 28 Jan 2026 17:10:00 +0000	Ares Capital Slips 10.4% in 6 Months: Should You Still Buy the Stock? ARCC shares fall 10.4% in six months as rate cuts squeeze yields, but robust originations, income growth and dividends test the bear case.
Wed, 28 Jan 2026 04:34:38 +0000	A Look At Hercules Capital (HTGC) Valuation After The Expanded Savara Loan Agreement Why the Savara loan amendment matters for Hercules Capital Hercules Capital (HTGC) drew investor attention after Savara Inc. amended its loan and security agreement, creating access to up to an additional $75 million of capital tied to FDA approval of MOLBREEVI. For Hercules, this updated facility shapes its exposure to Savara’s potential commercialization plans, since the added capacity, alongside Savara’s $75 million royalty financing, points to a larger pool of non dilutive funding linked...
Tue, 27 Jan 2026 13:05:00 +0000	Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI* LANGHORNE, Pa., January 27, 2026--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the amendment of its loan and security agreement with Hercules Capital, Inc. (NYSE:HTGC), strengthening its balance sheet and liquidity.
Mon, 26 Jan 2026 04:37:53 +0000	2 Financials Stocks for Long-Term Investors and 1 We Turn Down Financial firms serve as the backbone of the economy, providing essential services from lending and investment management to risk management and payment processing. But worries about economic uncertainty and potential market volatility have kept sentiment in check, and over the past six months, the industry's 3.2% return has trailed the S&P 500 by 4.9 percentage points.
Tue, 20 Jan 2026 22:35:00 +0000	enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc. BOSTON & MONTREAL, January 20, 2026--enGene Holdings Inc. (Nasdaq: ENGN, "enGene" or the "Company"), a clinical-stage, non-viral genetic medicines company, today announced that it has entered into an amendment to an amended and restated loan and security agreement (as amended, the "Loan Agreement") with two of its subsidiaries and Hercules Capital, Inc. (NYSE: HTGC) ("Hercules"), as agent, for up to US$125 million. Access to the additional non-dilutive capital strengthens enGene’s balance sheet
Thu, 15 Jan 2026 13:19:32 +0000	The Russell 2000 Is Crushing 2026: 4 Red-Hot High-Yield Dividend Stocks to Buy Now Four top small caps look like incredible buys now for growth and income investors looking for total return and huge passive income potential.
Wed, 14 Jan 2026 23:15:04 +0000	Hercules Capital (HTGC) Rises As Market Takes a Dip: Key Facts In the closing of the recent trading day, Hercules Capital (HTGC) stood at $18.84, denoting a +1.67% move from the preceding trading day.
Thu, 08 Jan 2026 20:15:59 +0000	Has Hercules Capital (HTGC) Pullback Created A New Opportunity For Investors? If you are wondering whether Hercules Capital shares still offer value at around US$18.24, it helps to step back and look at what the recent price action and fundamentals are really telling you. The stock has been relatively flat over the last year with a 0.9% return. That sits alongside a 3.1% decline over the past week, a 3.9% decline over the past month, and a 3.3% decline year to date, while the 3 year and 5 year returns of 87.2% and 114.6% respectively suggest a very different longer...
Thu, 08 Jan 2026 16:31:00 +0000	ARCC vs. HTGC: Which BDC Stock Is Positioned Better for Growth? Does HTGC's venture-focused lending, rising commitments and 2026 earnings growth outlook give it an edge over ARCC as BDC demand rebounds?
Tue, 06 Jan 2026 23:15:05 +0000	Hercules Capital (HTGC) Stock Declines While Market Improves: Some Information for Investors Hercules Capital (HTGC) closed the most recent trading day at $18.61, moving 1.22% from the previous trading session.
Tue, 06 Jan 2026 04:34:05 +0000	3 Value Stocks That Concern Us Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Fri, 26 Dec 2025 23:00:03 +0000	Hercules Capital (HTGC) Increases Despite Market Slip: Here's What You Need to Know In the closing of the recent trading day, Hercules Capital (HTGC) stood at $18.69, denoting a +1.08% move from the preceding trading day.
Thu, 18 Dec 2025 17:19:00 +0000	HawkEye 360 Closes Strategic Acquisition and Secures Series E Preferred and Debt HawkEye 360, the global leader in signals intelligence data and analytics, today announced the completion of its acquisition of Innovative Signal Analysis (ISA), supported by equity and debt financings totaling $150 million.

If you are already a Value Forum member but are not logged on, click here to log on. If you are a guest, thank you for visiting ValueForum -- click here for information about guest access or click here to join -- a Trial Pass can be purchased for $6.99 to help you decide if you want to commit to longer term membership. Did you know there are customized portals into VF like BDCs.ValueForum.com and also My ValueForum which lets you customize your VF experience to the posters and topics that most interest you!